Free Trial
TSE:TH

Theratechnologies (TH) Stock Price, News & Analysis

Theratechnologies logo
C$2.50 +0.10 (+4.17%)
(As of 12/20/2024 05:18 PM ET)

About Theratechnologies Stock (TSE:TH)

Key Stats

Today's Range
C$2.28
C$2.55
50-Day Range
C$1.67
C$2.56
52-Week Range
C$1.59
C$3.43
Volume
50,062 shs
Average Volume
32,685 shs
Market Capitalization
C$114.95 million
P/E Ratio
N/A
Dividend Yield
3.76%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Receive TH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

TH Stock News Headlines

Theratechnologies Seeks FDA Approval for Manufacturing Changes to EGRIFTA SV®
This is the worst sign for the U.S. stock market in 50 years
The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"
Theratechnologies Secures New $75 Million Credit Facilities
Theratechnologies Resubmits Tesamorelin Application to FDA
See More Headlines

TH Stock Analysis - Frequently Asked Questions

Theratechnologies' stock was trading at C$2.14 at the beginning of 2024. Since then, TH shares have increased by 16.8% and is now trading at C$2.50.
View the best growth stocks for 2024 here
.

Theratechnologies Inc. (TSE:TH) posted its quarterly earnings data on Thursday, October, 10th. The company reported $0.09 earnings per share for the quarter. The firm had revenue of $30.96 million for the quarter. Theratechnologies had a negative net margin of 8.47% and a negative trailing twelve-month return on equity of 1,116.86%.

Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Theratechnologies investors own include Theratechnologies (THTX), Stars Group (TSGI), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Vanguard Extended Duration Treasury ETF (EDV) and Nemaska Lithium (NMX).

Company Calendar

Last Earnings
10/10/2024
Today
12/22/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Restaurants, Hotels, Motels
CIK
N/A
Fax
N/A
Employees
103
Year Founded
N/A

Profitability

Net Income
C$-7,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$82.57 million
Cash Flow
C$0.66 per share
Book Value
C($0.50) per share

Miscellaneous

Free Float
N/A
Market Cap
C$114.95 million
Optionable
Not Optionable
Beta
1.73
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (TSE:TH) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners